Histopathological Patterns of Cutaneous Adverse Reaction to Anti-SARS-CoV-2 Vaccines: The Integrative Role of Skin Biopsy
Author:
Cazzato Gerardo1ORCID, Ambrogio Francesca2, Pisani Maria2, Colagrande Anna1ORCID, Arezzo Francesca3, Cascardi Eliano45ORCID, Dellino Miriam3ORCID, Macorano Enrica6ORCID, Trilli Irma7ORCID, Parente Paola8ORCID, Lettini Teresa1ORCID, Romita Paolo2, Marzullo Andrea1, Ingravallo Giuseppe1ORCID, Foti Caterina2
Affiliation:
1. Section of Molecular Pathology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari “Aldo Moro”, 70124 Bari, Italy 2. Section of Dermatology and Venereology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari “Aldo Moro”, 70124 Bari, Italy 3. Section of Gynecology and Obstetrics, IRCSS Giovanni Paolo II, 70124 Bari, Italy 4. Department of Medical Sciences, University of Turin, 10124 Turin, Italy 5. Pathology Unit, FPO-IRCCS Candiolo Cancer Institute, Str. Provinciale 142 lm 3.95, 10060 Candiolo, Italy 6. Section of Legal Medicine, Department of Interdisciplinary Medicine, University of Bari “Aldo Moro”, 70124 Bari, Italy 7. Odontomatostologic Clinic, Department of Innovative Technologies in Medicine and Dentistry, University of Chieti “G. D’Annunzio”, 66100 Chieti, Italy 8. Pathology Unit, Fondazione IRCCS Ospedale Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy
Abstract
The advent of vaccines represented a milestone to allow the slowing down and then containing of the exponential increase in ongoing infections and deaths of COVID-19. Since the first months of the vaccination campaign in various continents, there has been a certain number of reports of adverse events, including skin reactions. We conducted a systematic review, searching on PubMed, Web of Science, Scopus, and Cochrane Library for the words: COVID vaccine, dermatopathology, skin, eruptions, rash, cutaneous, BNT162b2 (Pfizer-BioNTech), ChAdOX1 (AstraZeneca), and mRNA-1273 (Moderna). A total of 28 records were initially identified in the literature search of which two were duplicates. After screening for eligibility and inclusion criteria, 18 publications were ultimately included. Various clinical cutaneous manifestations and histopathological patterns following vaccination have been described in literature. The most frequent clinical-pathological presentations were erythematous maculo-papular eruptions in different way of distribution with histopathological pictures mostly represented by interface changes and mixed peri-vascular and peri-adnexal cell infiltrate. Other presentations included new onset of pemphigoid bullous disease (n = 15), delayed T-cell-mediated hypersensitivity reaction (injection site reactions) (n = 10), purpuric skin rash (n = 13), mostly localized on the legs bilaterally and symmetrically with histological pictures characterized by extravasation of erythrocytes in the superficial and middle dermis, and other types of reactions. New studies with large case series and further literature reviews are needed to improve the clinical management of patients and optimize the timeline for carrying out histological biopsy for confirmatory, supportive, and differential diagnosis purposes.
Subject
Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology
Reference43 articles.
1. SARS-CoV-2 and its variants of concern including Omicron: A never ending pandemic;Mohapatra;Chem. Biol. Drug Des.,2022 2. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets;Delorey;Nature,2021 3. Dellino, M., Lamanna, B., Vinciguerra, M., Tafuri, S., Stefanizzi, P., Malvasi, A., Di Vagno, G., Cormio, G., Loizzi, V., and Cazzato, G. (2022). SARS-CoV-2 Vaccines and Adverse Effects in Gynecology and Obstetrics: The First Italian Retrospective Study. Int. J. Environ. Res. Public Health, 19. 4. Cazzato, G., Cascardi, E., Colagrande, A., Foti, C., Stellacci, A., Marrone, M., Ingravallo, G., Arezzo, F., Loizzi, V., and Solimando, A.G. (2022). SARS-CoV-2 and Skin: New Insights and Perspectives. Biomolecules, 12. 5. SARS-CoV-2 Variants, Vaccines, and Host Immunity;Mistry;Front. Immunol.,2022
|
|